"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Dr. Martínez-Lage shares Alzheimer's breakthroughs: why early diagnosis matters, the 4-step treatment plan for autonomy, and ...

Stroke specialist from Apollo Hospitals clarifies why menopause is a major trigger for stroke. Know the early signs to protect yourself before a stroke strikes.

Dr. Nicholas Suite, a neurologist in South Florida, recently shared his encounter with the Rebbe while he was working in New ...

As President of the Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) in Beijing, China, ...

That approach is exactly what nurse navigators are built for.

In this video, Andres Deik, MD, MSEd, FAAN, discusses the results of the CYCLE-II trial, presented at the 2025 International Congress of Parkinson’s Disease and Movement Disorders.

In this video, Andres Deik, MD, MSEd, FAAN, discusses the results of the CYCLE-II trial, presented at the 2025 International Congress of Parkinson’s Disease and Movement Disorders.

Dr. Joel Salinas, founder and chief medical officer of Isaac Health, examines the growing dementia crisis as a looming ...

We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...

Focal treatment-resistant epilepsy improves over time, but seizure reduction appears to be unrelated to specific medications ...

Expanded digital neurology capabilities strengthen hospital neurology programs by keeping patients in-houseFort Myers, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- TeleSpecialists, a physician-led digital ...